HSR26-257: Trends and Disparities in Next-Generation Sequencing and Targeted Therapy Uptake in Metastatic Biliary Tract Cancers: A Real-World Analysis
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Divya Samat und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Internal Medicine, Reading Hospital-Tower Health, West Reading, PA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Internal Medicine, Reading Hospital-Tower Health, West Reading, PA.
- 2Medical Oncology and Hematology, Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Zitieren
APA
Samat, D., Singh, S., & Talsania, A. (2026). HSR26-257: Trends and Disparities in Next-Generation Sequencing and Targeted Therapy Uptake in Metastatic Biliary Tract Cancers: A Real-World Analysis. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7242
Vancouver
Samat D, Singh S, Talsania A. HSR26-257: Trends and Disparities in Next-Generation Sequencing and Targeted Therapy Uptake in Metastatic Biliary Tract Cancers: A Real-World Analysis. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7242
BibTeX
@article{Samat2026,
author = {Samat, Divya and Singh, Shivam and Talsania, Ashita},
title = {HSR26-257: Trends and Disparities in Next-Generation Sequencing and Targeted Therapy Uptake in Metastatic Biliary Tract Cancers: A Real-World Analysis},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7242}
}
EUVIMED